Cargando…
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically actionable aberrations across numerous cancer types in real-time. With the development of new therapeutic agents in prostate cancer (PC) including DNA repair targeted therapies, this is especially attract...
Autores principales: | Trujillo, Blanca, Wu, Anjui, Wetterskog, Daniel, Attard, Gerhardt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553885/ https://www.ncbi.nlm.nih.gov/pubmed/35715640 http://dx.doi.org/10.1038/s41416-022-01881-9 |
Ejemplares similares
-
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
por: González-Billalabeitia, Enrique, et al.
Publicado: (2018) -
Exosome-based liquid biopsies in cancer: opportunities and challenges
por: Yu, W., et al.
Publicado: (2021) -
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
por: Romano, Chiara, et al.
Publicado: (2021) -
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019) -
Genome-wide plasma DNA methylation features of metastatic prostate cancer
por: Wu, Anjui, et al.
Publicado: (2020)